Video

It Takes a Team to Build Personalized Care for Type 2 Diabetes

Diana McNeill, MD, of Duke University Medical Center moderated a panel at the American College of Physicians Internal Medicine Meeting (ACP 2017) in San Diego, California. The topic of discussion? Personalized care in type 2 diabetes.

It goes without saying that not every patient with the same health condition is similar. In the case of type 2 diabetes, teamwork can better help patients manage their disease with personalized care.

Diana McNeill, MD, professor of medicine and assistant professor of obstetrics and gynecology at Duke University Medical Center in Durham, North Carolina moderated a panel at the American College of Physicians Internal Medicine Meeting (ACP 2017) in San Diego, California. With panelists Steven Edelman, MD, and M. Sue Kirkman, MD, the physicians talked about preventing clinical inertia in the management of type 2 diabetes and the importance of personalized care.

McNeill spoke with MD Magazine about the discussion and said that the type 2 diabetes epidemic puts many patients in front of primary care physicians before an endocrinologist.

“When a patient comes into your office, do you examine them and check their feet and make sure that they’ve had all their diabetes healthcare maintenance completed?” McNeill said. “And once you do do that, what target of diabetes control are you aiming for? And is it appropriate for their age and comorbidities?”

She went on to explain that the American Diabetes Association has changed their thinking on the goals of type 2 diabetes care. How? Watch the video above and gain insight on personalized care.

>>> More Coverage from ACP 2017

Related Videos
Caroline Piatek, MD: High HCRU, Patient Concerns Highlight Great Unmet Need in wAIHA
Steven W. Pipe, MD: Supporting Gene Therapy Implementation for Hemophilia
Corinna L. Schultz, MD: Improving Sickle Cell Trait Documentation in Infancy
Sibgha Zaheer, MD: Determining Washout Period With Fitusiran, Emicizumab Transition for Hemophilia
Pavan K. (Tem) Bendapudi, MD: Large-Scale Analyses Elucidate Genetic Risk of Thrombosis
Seema Rani, MD: Examining Sleep Health in Youth With SCD
Daniel Wang: A More Appropriate Ferritin Threshold is Cost-Effective for Iron Deficiency Screening
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
© 2025 MJH Life Sciences

All rights reserved.